Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block – sources

HONG KONG (Reuters) – U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.
( read original story …)


Related Post

Sichuan spicy hotpot chain Haidilao prepares for H...
views 5
Haidilao International Holding, considered China’s...
Hong Kong can take advantage of national funding f...
views 22
Hong Kong’s financial secretary has urged local de...
Hong Kong’s millennials join red-hot property part...
views 20
Hong Kong’s millennials, fearing that they will so...
Top Philippine diplomat in Hong Kong Antonio Moral...
views 25
While Hong Kong has opened its doors to domestic h...
Beijing police ‘edited’ video to mislead public ov...
views 31
The Hong Kong Journalists Association slammed main...
Hong Kong to reach decision by November on lifting...
views 28
On Saturday Japanese news agency Kyodo reported th...
Don’t be demoralised by Occupy failure – change go...
views 31
Hongkongers should not be demoralised by the failu...
Hong Kong children expose their identities, though...
views 32
Hundreds of Hong Kong children, some as young as n...
How Hong Kong is making it hard for young couples ...
views 34
The young couple had a traditional wedding in the ...
Hong Kong’s Retailers Ride High on Shopping ...
views 31
Then there’s the specter of rising borrowing costs...